This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Axceso Biopharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Si-Eun Yun: Innovator in Cancer Treatment
Introduction
Si-Eun Yun is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in cancer treatment. His innovative work has led to the creation of a patent that holds promise for future medical applications.
Latest Patents
Si-Eun Yun holds a patent for a pyrimido pyrimidinone compound and a pharmaceutical composition comprising the same. This compound is designed to inhibit PD-L1 expression, which is crucial in the treatment and prevention of cancer. The patent outlines the uses of this compound or composition, highlighting its potential effectiveness in combating cancer.
Career Highlights
Throughout his career, Si-Eun Yun has been associated with Axceso Biopharma Co., Ltd., where he has focused on research and development in the pharmaceutical sector. His work has been instrumental in advancing the understanding of cancer treatment options.
Collaborations
Si-Eun Yun has collaborated with notable colleagues, including Young Jun Park and Sung Jun Park. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.
Conclusion
Si-Eun Yun's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work at Axceso Biopharma Co., Ltd. and collaborations with fellow researchers underscore the importance of teamwork in achieving breakthroughs in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile